Zacks Research Upgrades Adtalem Global Education (NYSE:CVSA) to Strong-Buy

Posted by on Feb 26th, 2026

Adtalem Global Education (NYSE:CVSA – Get Free Report) was upgraded by stock analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports.

Adtalem Global Education Price Performance

Adtalem Global Education Company Profile

(Get Free Report)

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

Featured Stories

Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.